Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Wellington Partners
Deal Size : $12.5 million
Deal Type : Financing
Details : The proceeds from the round will be used to further advance the company’s proprietary technology platform to build a pipeline of therapeutic candidates towards first-in-human readiness as well as to expand the company’s presence in the EU & US.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
March 16, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Wellington Partners
Deal Size : $12.5 million
Deal Type : Financing
Reset All
